Global Drainage Endobronchial Blocker Market Growth 2026-2032
Description
The global Drainage Endobronchial Blocker market size is predicted to grow from US$ 292 million in 2025 to US$ 367 million in 2032; it is expected to grow at a CAGR of 3.4% from 2026 to 2032.
A drainage-type endobronchial blocker is a specially designed medical device that can be inserted into the bronchus to block the ventilation of a specific lobe or segment of the lung and has a drainage function. This device is usually inserted through a bronchoscope or fiber bronchoscope to ensure accurate placement. A drainage-type endobronchial blocker usually consists of a catheter for guiding the blocker into the bronchus, an inflatable balloon part for tightly fitting the bronchial wall to achieve the blocking function, an inflation connector for connecting an inflation device to inflate or deflate the balloon, and a drainage channel designed to drain liquid or gas in the bronchus.
United States market for Drainage Endobronchial Blocker is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Drainage Endobronchial Blocker is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Drainage Endobronchial Blocker is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Drainage Endobronchial Blocker players cover 3M, Solvay, DuPont, BASF, Chemours, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the “Drainage Endobronchial Blocker Industry Forecast” looks at past sales and reviews total world Drainage Endobronchial Blocker sales in 2025, providing a comprehensive analysis by region and market sector of projected Drainage Endobronchial Blocker sales for 2026 through 2032. With Drainage Endobronchial Blocker sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Drainage Endobronchial Blocker industry.
This Insight Report provides a comprehensive analysis of the global Drainage Endobronchial Blocker landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Drainage Endobronchial Blocker portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Drainage Endobronchial Blocker market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Drainage Endobronchial Blocker and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Drainage Endobronchial Blocker.
This report presents a comprehensive overview, market shares, and growth opportunities of Drainage Endobronchial Blocker market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Unilateral Blocking
Bilateral Blocking
Segmentation by Application:
Treatment of Respiratory Diseases
Chest Surgery
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
3M
Solvay
DuPont
BASF
Chemours
AGC Chemicals
Nantong Xingchen Synthetic Materials
Xinguang Chemical
Wanhua Chemical
Dongyue Group
Key Questions Addressed in this Report
What is the 10-year outlook for the global Drainage Endobronchial Blocker market?
What factors are driving Drainage Endobronchial Blocker market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Drainage Endobronchial Blocker market opportunities vary by end market size?
How does Drainage Endobronchial Blocker break out by Type, by Application?
Please note: The report will take approximately 2 business days to prepare and deliver.
A drainage-type endobronchial blocker is a specially designed medical device that can be inserted into the bronchus to block the ventilation of a specific lobe or segment of the lung and has a drainage function. This device is usually inserted through a bronchoscope or fiber bronchoscope to ensure accurate placement. A drainage-type endobronchial blocker usually consists of a catheter for guiding the blocker into the bronchus, an inflatable balloon part for tightly fitting the bronchial wall to achieve the blocking function, an inflation connector for connecting an inflation device to inflate or deflate the balloon, and a drainage channel designed to drain liquid or gas in the bronchus.
United States market for Drainage Endobronchial Blocker is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Drainage Endobronchial Blocker is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Drainage Endobronchial Blocker is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Drainage Endobronchial Blocker players cover 3M, Solvay, DuPont, BASF, Chemours, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the “Drainage Endobronchial Blocker Industry Forecast” looks at past sales and reviews total world Drainage Endobronchial Blocker sales in 2025, providing a comprehensive analysis by region and market sector of projected Drainage Endobronchial Blocker sales for 2026 through 2032. With Drainage Endobronchial Blocker sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Drainage Endobronchial Blocker industry.
This Insight Report provides a comprehensive analysis of the global Drainage Endobronchial Blocker landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Drainage Endobronchial Blocker portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Drainage Endobronchial Blocker market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Drainage Endobronchial Blocker and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Drainage Endobronchial Blocker.
This report presents a comprehensive overview, market shares, and growth opportunities of Drainage Endobronchial Blocker market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Unilateral Blocking
Bilateral Blocking
Segmentation by Application:
Treatment of Respiratory Diseases
Chest Surgery
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
3M
Solvay
DuPont
BASF
Chemours
AGC Chemicals
Nantong Xingchen Synthetic Materials
Xinguang Chemical
Wanhua Chemical
Dongyue Group
Key Questions Addressed in this Report
What is the 10-year outlook for the global Drainage Endobronchial Blocker market?
What factors are driving Drainage Endobronchial Blocker market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Drainage Endobronchial Blocker market opportunities vary by end market size?
How does Drainage Endobronchial Blocker break out by Type, by Application?
Please note: The report will take approximately 2 business days to prepare and deliver.
Table of Contents
104 Pages
- *This is a tentative TOC and the final deliverable is subject to change.*
- 1 Scope of the Report
- 2 Executive Summary
- 3 Global by Company
- 4 World Historic Review for Drainage Endobronchial Blocker by Geographic Region
- 5 Americas
- 6 APAC
- 7 Europe
- 8 Middle East & Africa
- 9 Market Drivers, Challenges and Trends
- 10 Manufacturing Cost Structure Analysis
- 11 Marketing, Distributors and Customer
- 12 World Forecast Review for Drainage Endobronchial Blocker by Geographic Region
- 13 Key Players Analysis
- 14 Research Findings and Conclusion
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
